Cargando…

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients

BACKGROUND: Patients with low cardiovascular disease (CVD) risk potentially use preventive cardiovascular medication unnecessarily. Our aim was to identify various viewpoints and beliefs concerning the preventive CVD management of patients with low CVD risk using preventive cardiovascular medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luymes, Clare H, Boelhouwer, Nelleke J, Poortvliet, Rosalinde KE, de Ruijter, Wouter, Reis, Ria, Numans, Mattijs E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449103/ https://www.ncbi.nlm.nih.gov/pubmed/28579760 http://dx.doi.org/10.2147/PPA.S131625

Ejemplares similares

Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial
por: Luymes, Clare H., et al.
Publicado: (2018)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
por: Rozsnyai, Zsofia, et al.
Publicado: (2020)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Assessment of Appropriateness of Cardiovascular Preventive Medication in Adults ≥ 75 years
por: van der Ploeg, Milly, et al.
Publicado: (2020)

Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study
por: van Middelaar, Tessa, et al.
Publicado: (2018)

Understanding older patients’ willingness to have medications deprescribed in primary care: a protocol for a cross-sectional survey study in nine European countries
por: Lüthold, Renata Vidonscky, et al.
Publicado: (2022)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

The effect of ultraviolet irradiation compared to oral vitamin D supplementation on blood pressure of nursing home residents with dementia
por: Veleva, Bistra I., et al.
Publicado: (2021)

Methodological Challenges for Epidemiologic Studies of Deprescribing at the End of Life
por: Tjia, Jennifer, et al.
Publicado: (2021)

Perspectives on cancer screening participation in a highly urbanized region: a Q-methodology study in The Hague, the Netherlands
por: Bongaerts, Thomas H. G., et al.
Publicado: (2022)

Understanding Global Deprescribing Policy: Opportunities and Challenges
por: Kim, Catherine, et al.
Publicado: (2021)

General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Publisher Correction: Perspectives on cancer screening participation in a highly urbanized region: a Q-methodology study in the Hague, the Netherlands
por: Bongaerts, Thomas H.G, et al.
Publicado: (2022)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Improving access to school health services as perceived by school professionals
por: Bezem, Janine, et al.
Publicado: (2017)

Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Poortvliet, Rosalinde K. E., et al.
Publicado: (2012)

Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method
por: van der Ploeg, Milly A., et al.
Publicado: (2022)

A methodological framework for evaluating transitions in acute care services in the Netherlands to achieve Triple Aim
por: Minderhout, Rosa Naomi, et al.
Publicado: (2022)

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
por: Brunner, Laureline, et al.
Publicado: (2022)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Bootstrapping Q Methodology to Improve the Understanding of Human Perspectives
por: Zabala, Aiora, et al.
Publicado: (2016)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Care use and its intensity in children with complex problems are related to varying child and family factors: A follow-up study
por: Pannebakker, Noortje M., et al.
Publicado: (2020)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Lower Performance in Orientation to Time and Place Associates with Greater Risk of Cardiovascular Events and Mortality in the Oldest Old: Leiden 85-Plus Study
por: Rostamian, Somayeh, et al.
Publicado: (2017)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

The COVID-19 Crisis as a Teachable Moment for Lifestyle Change in Dutch Cardiovascular Disease Patients
por: Brust, Michelle, et al.
Publicado: (2021)

Deprescribing in cardiometabolic conditions in older patients: a systematic review
por: Hickman, Elizabeth, et al.
Publicado: (2023)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

When and how to use Q methodology to understand perspectives in conservation research
por: Zabala, Aiora, et al.
Publicado: (2018)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases
por: Bogaerts, Jonathan M K, et al.
Publicado: (2021)

Selective prevention of cardiovascular disease using integrated lifestyle intervention in primary care: protocol of the Healthy Heart stepped-wedge trial
por: Bonten, Tobias N, et al.
Publicado: (2021)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Deprescribing: Fashion Accessory or Fig Leaf?
por: Zermansky, Arnold G.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_luvjtdfk3rmqvfnmm96gq4illv